IP Library Granted Patent US 10,288,612
Granted Patent B2
US 10,288,612 · App. 15/358,864 · Granted May 14, 2019

Methods for diagnosing and treating eosinophilic esophagitis

Inventor: Patricia C. Fulkerson (Cincinnati, OH)
Assignee: Children's Hospital Medical Center
G01N33/56972A23L33/20A61K31/00G01N33/6893G01N2800/06G01N2800/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,288,612
App. No.
15/358,864
Granted
May 14, 2019
Kind
B2
Abstract

Disclosed are methods of diagnosing and treating a subject with active or inactive eosinophilic esophagitis (EoE). The methods may include the steps of detecting whether a level of eosinophil lineage-committed progenitor (EoP) is elevated in a blood sample obtained from a subject, diagnosing the subject with active EoE when an EoP level in the sample is elevated above a pre-determined cut-off value and diagnosing the subject with inactive EoE when the EoP level in the sample is below a pre-determined cut-off value; and treating the subject diagnosed with active EoE. Kits related to same are also disclosed.

Claims (6)

1. A method of diagnosing and treating a subject with active or inactive eosinophilic esophagitis (EoE) in a patient suffering from EoE, comprising the steps of

a. detecting whether a level of eosinophil lineage-committed progenitor (EoP) is elevated in a blood sample obtained from said subject;

b. diagnosing said subject with active EoE when said EoP level in the sample is elevated above a pre-determined cut-off value and diagnosing said subject with inactive EoE when said EoP level in the sample is below a pre-determined cut-off value; and

c. treating said subject diagnosed with active EoE;

wherein when said EoP level is below a cut-off of about 15.5 EoPs per mL (esophageal eosinophils/HPF) of blood, said subject is diagnosed with inactive EoE, and wherein when said EoP level is above a cut-off of about 15.5 EoPs per mL of blood, said subject is diagnosed with active EoE.

2. The method of claim 1 , wherein said treatment step comprises administration of steroids, administration of a proton-pump inhibitor, withdrawal of one or more food types, an amino-acid based formula diet, or a combination thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 2, 2017
From: CINCINNATI CHILDRENS HOSP MED CTR
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041590/0835 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2017
From: FULKERSON, PATRICIA C.
To: CHILDREN'S HOSPITAL MEDICAL CENTER
Reel/Frame 040903/0129 →
Continuity (2)
Provisional Application 62275959 · Jan 7, 2016
Related Publication 20170199191A1 · Jul 13, 2017